Keith Morrison

Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist

Marc Iglarz, Christoph A. Binkert, Keith Morrison et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 325 citations

Medicine, Medicinal Chemistry, Pharmacology +10

Pharmacology of the Urotensin-II Receptor Antagonist Palosuran (ACT-058362; 1-[2-(4-Benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea Sulfate Salt): First Demonstration of a Pathophysiological Role of the Urotensin System

Martine Clozel, Christoph A. Binkert, Magdalena Birker et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 132 citations · Full text

Medicine, Pharmacology, Molecular Pharmacology +12

Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension

Tetsuo Asaki, Keiichi Kuwano, Keith Morrison et al. · Journal of Medicinal Chemistry · 2015 · 88 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Novel Benzo[1,4]diazepin-2-one Derivatives as Endothelin Receptor Antagonists

Martin H. Bolli, Judith Marfurt, Corinna Grisostomi et al. · Journal of Medicinal Chemistry · 2004 · 77 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Selexipag: A Selective Prostacyclin Receptor Agonist that Does Not Affect Rat Gastric Function

Keith Morrison, Roland Ernst, Patrick Hess et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 63 citations

Medicine, Medicinal Chemistry, Pharmacology +13